Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ocular drug delivery. Pharmacokinetic considerations.

Literature DB >> 2182264

Ocular drug delivery. Pharmacokinetic considerations.

R D Schoenwald¹.

Abstract

Mesh：

Substances：

Year: 1990 PMID： 2182264 DOI： 10.2165/00003088-199018040-00001

Source DB: PubMed Journal: Clin Pharmacokinet ISSN： 0312-5963 Impact factor: 6.447

× No keyword cloud information.

90 in total

1. Intraocular penetration of topically applied lincomycin hydrochloride in rabbits.

Authors: J Kleinberg; F J Dea; J A Anderson; I H Leopold
Journal: Arch Ophthalmol Date: 1979-05

2. Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid.

Authors: R A Walstad; K B Hellum; S Blika; L G Dale; T Fredriksen; K I Myhre; G R Spencer
Journal: J Antimicrob Chemother Date: 1983-07 Impact factor: 5.790

3. Pilocarpic acid esters as novel sequentially labile pilocarpine prodrugs for improved ocular delivery.

Authors: H Bundgaard; E Falch; C Larsen; G L Mosher; T J Mikkelson
Journal: J Med Chem Date: 1985-08 Impact factor: 7.446

4. Topical carbonic anhydrase inhibitors IV: Relationship between excised corneal permeability and pharmacokinetic factors.

Authors: M G Eller; R D Schoenwald; J A Dixson; T Segarra; C F Barfknecht
Journal: J Pharm Sci Date: 1985-05 Impact factor: 3.534

5. Ocular pharmacology of sulfonamides: the cornea as barrier and depot.

Authors: T H Maren; L Jankowska
Journal: Curr Eye Res Date: 1985-04 Impact factor: 2.424

6. Disposition of cyclophosphamide in the rabbit and human cornea.

Authors: R D Schoenwald; J A Houseman
Journal: Biopharm Drug Dispos Date: 1982 Jul-Sep Impact factor: 1.627

7. Aqueous vs viscous phenylephrine. I. Systemic absorption and cardiovascular effects.

Authors: V Kumar; R D Schoenwald; W A Barcellos; D S Chien; J C Folk; T A Weingeist
Journal: Arch Ophthalmol Date: 1986-08

8. Ethoxzolamide analogue gel. A topical carbonic anhydrase inhibitor.

Authors: R A Lewis; R D Schoenwald; M G Eller; C F Barfknecht; C D Phelps
Journal: Arch Ophthalmol Date: 1984-12

9. Dipivalyl epinephrine: a new pro-drug in the treatment of glaucoma.

Authors: A I Mandell; F Stentz; A E Kitabchi
Journal: Ophthalmology Date: 1978-03 Impact factor: 12.079

10. Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors.

Authors: H F Edelhauser; T H Maren
Journal: Arch Ophthalmol Date: 1988-08

27 in total

1. Role of P-glycoprotein in ocular clearance of rhodamine 123 in rabbits.

Authors: T Kajikawa; H K Mishima; T Murakami; M Takano
Journal: Pharm Res Date: 2000-04 Impact factor: 4.200

2. Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye.

Authors: C S Rao; R D Schoenwald; C F Barfknecht; S L Laban
Journal: J Pharmacokinet Biopharm Date: 1992-08

3. Anti-Toxoplasma activity and impact evaluation of lyophilization, hot molding process, and gamma-irradiation techniques on CLH-PLGA intravitreal implants.

Authors: Gabriella M Fernandes-Cunha; Cíntia M F Rezende; Wagner N Mussel; Gisele R da Silva; Elionai C de L Gomes; Maria I Yoshida; Sílvia L Fialho; Alfredo M Goes; Dawison A Gomes; Ricardo W de Almeida Vitor; Armando Silva-Cunha
Journal: J Mater Sci Mater Med Date: 2015-12-16 Impact factor: 3.896

Ocular drug delivery. Pharmacokinetic considerations.

1. Intraocular penetration of topically applied lincomycin hydrochloride in rabbits.

2. Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid.

3. Pilocarpic acid esters as novel sequentially labile pilocarpine prodrugs for improved ocular delivery.

4. Topical carbonic anhydrase inhibitors IV: Relationship between excised corneal permeability and pharmacokinetic factors.

5. Ocular pharmacology of sulfonamides: the cornea as barrier and depot.

6. Disposition of cyclophosphamide in the rabbit and human cornea.

7. Aqueous vs viscous phenylephrine. I. Systemic absorption and cardiovascular effects.

8. Ethoxzolamide analogue gel. A topical carbonic anhydrase inhibitor.

9. Dipivalyl epinephrine: a new pro-drug in the treatment of glaucoma.

10. Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors.

1. Role of P-glycoprotein in ocular clearance of rhodamine 123 in rabbits.

2. Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye.

3. Anti-Toxoplasma activity and impact evaluation of lyophilization, hot molding process, and gamma-irradiation techniques on CLH-PLGA intravitreal implants.

4. [Pharmacokinetics of the anterior eye].

5. Controlled ocular delivery of acyclovir through rate controlling ocular insert of Eudragit: a technical note.

Review 6. New techniques for drug delivery to the posterior eye segment.

7. Formulation, in vitro dissolution, and ocular bioavailability of high- and low-melting phenylephrine oxazolidines.

Review 8. Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.

9. Dexamethasone diffusion across contact lenses is inhibited by Staphylococcus epidermidis biofilms in vitro.

10. In situ forming polymeric drug delivery systems.